Pemvidutide (ALT-801)

pemvidutide · Altimmune, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pemvidutide (ALT-801), covering 2025-06-24 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability [Phase 1]